Integra LifeSciences Holdings Corporation (IART)
After hours:
| Previous close | 38.72 |
| Open | 38.93 |
| Bid | 38.50 x 1400 |
| Ask | 38.58 x 800 |
| Day's range | 38.53 - 39.06 |
| 52-week range | 37.36 - 60.69 |
| Volume | |
| Avg. volume | 641,175 |
| Market cap | 3.139B |
| Beta (5Y monthly) | 1.20 |
| PE ratio (TTM) | 24.56 |
| EPS (TTM) | 1.57 |
| Earnings date | 24 Oct 2023 - 30 Oct 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 48.00 |
Simply Wall St.Integra LifeSciences Holdings (NASDAQ:IART) Has Some Way To Go To Become A Multi-Bagger
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...
GlobeNewswireIntegra LifeSciences to Present at the 2023 Wells Fargo Healthcare Conference
PRINCETON, N.J., Sept. 01, 2023 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2023 Wells Fargo Healthcare Conference on September 6, 2023 at 1:30 p.m. EST. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations. About Integra LifeSci
ZacksHere's Why You Should Retain Integra (IART) Stock for Now
Investors continue to be optimistic about Integra (IART) based on the prospects of its CSS segment and a stable liquidity position.
